Join Growin Stock Community!
Beta
Back to BBAI.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

BBAI Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q1'26, BBAI's operating expenses reached a total of $34.76M USD, with R&D Expenses at $5.53M USD and SG&A Expenses at $29.23M USD, marking the highest quarterly figure in the observed period and reflecting continued investment in operations. From Q2'23 to Q1'26, total operating expenses exhibited an overall upward trend, rising from $19.15M USD to $34.76M USD, driven primarily by steady growth in SG&A Expenses (from $16.93M USD to $29.23M USD) and volatile but generally increasing R&D Expenses (fluctuating between a low of -$0.35M USD in Q3'23 and a peak of $5.53M USD in Q1'26). Notable spikes occurred in Q2'24 ($26.99M USD total) and Q4'25 ($30.48M USD total), while the negative R&D value in Q3'23 suggests a one-time adjustment; SG&A consistently dominated, comprising 80-95% of totals across quarters, indicating heavy reliance on administrative and sales costs amid expansion.